Product Information
NEORAL 25 MG GELATIN CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $2.9457 per EA under NDC 00078024615. Its NADAC has been published 632 times since Nov 28, 2013.
FDA first approved this application on Jul 14, 1995. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078024615
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
7/8/2026
Active Ingredients
CYCLOSPORINEApproval Type
New Drug (NDA)
FDA Application
NDA050715FDA Approved
7/14/1995
TE Code
AB1
On Market Since
7/14/1995
Pharmacological Classes
Price Statistics
The NADAC for NEORAL 25 MG GELATIN CAPSULE has been published 632 times since Nov 28, 2013, and over the history we have for it it has risen 106.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9457 per EA |
|---|---|
| All-time high | $2.9457 (Aug 19, 2026) |
| All-time low | $1.4293 (Nov 28, 2013) |
| 52-week high | $2.9457 |
| 52-week low | $2.8297 |
| Median price | $2.1601 |
| Average price | $2.1396 |
| Largest weekly change | +9.9% (Jan 11, 2023) |
| Weeks tracked | 632 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NEORAL 25 MG GELATIN CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NEORAL 25 MG GELATIN CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $2.9457 per EA (NDC 00078024615), effective Aug 19, 2026.
How has the price of NEORAL 25 MG GELATIN CAPSULE changed over time?
Over the history we have for it, the NADAC for NEORAL 25 MG GELATIN CAPSULE has risen 106.1%. It has been tracked across 632 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEORAL 25 MG GELATIN CAPSULE?
Since Nov 28, 2013, the NADAC for NEORAL 25 MG GELATIN CAPSULE has ranged from a low of $1.4293 (Nov 28, 2013) to a high of $2.9457 (Aug 19, 2026), with a median of $2.1601 per EA.
Are there cheaper alternatives to NEORAL 25 MG GELATIN CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NEORAL 25 MG GELATIN CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures NEORAL 25 MG GELATIN CAPSULE?
NEORAL 25 MG GELATIN CAPSULE (NDC 00078024615) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.